Showing results (91-100 of 139) with videos related to
Sort By:
Pageof 14
Transplant International : Official Journal of the European Society for Organ Transplantation|February 11, 2012
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantationMarkus Guba, Johann Pratschke, Christian Hugo, et al.Langenbeck'S Archives of Surgery|March 11, 2016
Rescue management of early complications after liver transplantation-key for the long-term successJoachim Andrassy, Sebastian Wolf, Verena Hoffmann, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2020
Liver transplantation in a patient after COVID-19 - Rapid loss of antibodies and prolonged viral RNA sheddingHanno Niess, Nikolaus Börner, Maximilian Muenchhoff, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|February 20, 2025
Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft OutcomeDominik Thomas Koch, Micol Tamai, Malte Schirren, et al.Transplantation|May 29, 2004
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed miceGudrun E Koehl, Joachim Andrassy, Markus Guba, et al.Transplantation Direct|August 9, 2016
Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC LiversSebastian Pratschke, Hannah Arnold, Alfred Zollner, et al.Surgery|November 30, 2021
Specific intraoperative antibiotic therapy abrogates the negative effect of biliary contamination on the Comprehensive Complication Index after pancreatic head resectionElise Pretzsch, Anna Heim, Christian Heiliger, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrenceLakhbir Sandhu, Charbel Sandroussi, Markus Guba, et al.Nature Medicine|February 1, 2002
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorMarkus Guba, Philipp von Breitenbuch, Markus Steinbauer, et al.Journal of Clinical Medicine|November 11, 2022
A Novel Deep Learning Model as a Donor-Recipient Matching Tool to Predict Survival after Liver TransplantationNikolaus Börner, Markus B Schoenberg, Philipp Pöschke, et al.Pageof 14